Table 1 Patients’ characteristics, with and without infection

PICU length of stay (days)

7.7 (IQR 3–19)

24.1 (IQR 14.9–36.9)

0.002

VA-ECMO run length (days)

3.1 (IQR 1.9–6.3)

6.6 (IQR 4.5–9.4)

0.009

Age at VA-ECMO (months)

41.2 (IQR 12.9–81.8)

40.3 (IQR 9.8–112.9)

0.62

Weight (kg)

12 (IQR 7.2–20)

11 (IQR 5.7–26.8)

0.84

Hospitalized in PICU at VA-ECMO

11 (40,7)

6 (42,9)

0,9

VA-ECMO inserted in the OR

18 (66.7)

7 (50)

VA-ECMO inserted in the ER

2 (7.4)

1 (7,1)

VA-ECMO inserted in the PICU

7 (25.9)

6 (42,9)

0,6

Central VA-ECMO

21 (77.8)

12 (85.7)

Peripheral VA-ECMO

4 (14.8)

2 (14.3)

Peripheral converted to central

2 (7.4)

0(0)

0,8

Leucocytes (G/L)^a

9.9 (IQR 5.7–13.6)

10.6 (IQR 8.2–13.3)

0.51

Platelets (G/L)^a

69 (IQR 35–133)

74 (IQR 69–133)

0.45

CRP (mg/L)^a

10 (IQR 10–33.5)

18 (IQR 10–76)

0.29

Blood glucose (mmol/L)^a

7.8 (IQR 5.1–14.6)

9.8 (IQR 6.8–14.6)

0.37

Deceased

15 (55%)

7 (50%)

0.75